3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
16
Carcinoma, Renal Cell
14
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Neoplasms
6
Carcinoma, Medullary
6
Thyroid Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Neuroendocrine Tumors
4
Carcinoma, Transitional Cell
4
Brain Neoplasms
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Kidney Neoplasms
3
Adenocarcinoma, Follicular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Pain
2
Osteosarcoma
2
Multiple Myeloma
2
Interventions
Sunitinib
3
avelumab
2
Nutrition Assessment
2
Axitinib
2
spartalizumab
1
pembrolizumab
1
etelcalcetide hydrochloride
1
aldesleukin
1
Sorafenib
1
Resistance Training
1
Plasma Exchange
1
Interleukin-2
1
Adalimumab
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Diseases
×
cabozantinib
×
Clear all
No trials found.